Eti Mitrany

Eti Mitrany is the current Director at Brainsway. Prior to this, they were with Teva Pharmaceuticals for over 24 years, where they were most recently the SVP CFO - Head of Teva Business Planning & Analysis. In this role, they were responsible for leading key financial global activities and processes for the company, including managing the Teva corporate global economics department, overseeing Long Range and Annual Planning (LRP & AOP), providing analytics to the Executive Committee, Board of Directors and shareholders, and developing KPI and incentive programs. Eti also played a key role in executing a $3.0 billion restructuring program and was a partner to major acquired company integrations. In addition, they managed the Teva FP&A community of over 500 FTEs, as well as the Teva corporate economics and information departments (~50 FTEs). Eti also worked closely with IQVIA on corporate information department matters. Prior to their role at Teva Pharmaceuticals, Eti Mitrany was with BrainsWay.

Eti Mitrany has completed an MBA in Finance & Marketing from Tel Aviv University, as well as a BA in Business/Managerial Economics from the same institution.